West Pharmaceutical Services, Inc.
WST
Rang in Aktien
#890
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Aktienkurs
$384.10
Marktkapitalisierung
$27.03B
Veränderung (1 Tag)
0.16%
Veränderung (1 Jahr)
41.94%
Land
US
Handel West Pharmaceutical Services, Inc. (WST)
Kategorie
Healthcare
Operative Marge für West Pharmaceutical Services, Inc. (WST)
Operative Marge zum October 2026 TTM: 20.64%
Laut den neuesten Finanzberichten und dem Aktienkurs von West Pharmaceutical Services, Inc. beträgt die aktuelle operative Marge (TTM) 20.64%. Am Ende des Jahres 2023 lag die operative Marge bei 24.09%.
Historie der operativen Marge von West Pharmaceutical Services, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 20.64% | 0.39% |
| 2024 | 20.56% | -14.65% |
| 2023 | 24.09% | -8.96% |
| 2022 | 26.46% | -1.27% |
| 2021 | 26.80% | 37.30% |
| 2020 | 19.52% | 21.09% |
| 2019 | 16.12% | 8.70% |
| 2018 | 14.83% | 3.34% |
| 2017 | 14.35% | 0.49% |
| 2016 | 14.28% | 58.84% |
| 2015 | 8.99% | -29.71% |
| 2014 | 12.79% | 11.70% |
| 2013 | 11.45% | 6.22% |
| 2012 | 10.78% | 10.91% |
| 2011 | 9.72% | 1.25% |
| 2010 | 9.60% | -4.38% |
| 2009 | 10.04% | -15.27% |
| 2008 | 11.85% | 6.95% |
| 2007 | 11.08% | -4.24% |
| 2006 | 11.57% | 10.61% |
| 2005 | 10.46% | -11.36% |
| 2004 | 11.80% | 6.21% |
| 2003 | 11.11% | 74.69% |
| 2002 | 6.36% | -38.90% |
| 2001 | 10.41% | 25.42% |
| 2000 | 8.30% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 31.28% | -98.48% |
US
|
|
| 12.36% | -99.40% |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | -99.52% |
US
|
|
| 0.00% | - |
CH
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.